Enbrel Liquid Immunogenicity Protocol

This study has been completed.
Sponsor:
Collaborator:
Immunex Corporation
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT00249041
First received: November 3, 2005
Last updated: July 29, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Publications: